U.S. Food and Drug Administration Gives Huxley Medical 510(k) Clearance for SANSA Home Sleep Apnea Test

ATLANTA, Aug. 7, 2024 /PRNewswire/ -- Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking, chest-worn, sleep apnea diagnostic patch, SANSA.

The patch is a first-of-its-kind, at-home, single-point-of-skin-contact diagnostic device and represents a breakthrough in medical innovation. Unlike current patches, rings, watches, or finger probes, SANSA does not require additional attachments, wires, belts, or hoses.

Its patented combination of sensors and materials precisely measures eight physiological channels including blood oxygen saturation, EKG-derived heart rate, respiratory effort, chest movement, sleep staging, snoring, body position, and actigraphy.

Sign up for Blog Updates